AI assistant
GENETIC TECHNOLOGIES LIMITED — Board/Management Information 2012
Nov 27, 2012
65022_rns_2012-11-27_98599c1c-9c60-4fb5-a09a-b4678134da3d.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [592 x 69] intentionally omitted <==
==> picture [592 x 69] intentionally omitted <==
ASX ANNOUNCEMENT November 28[th] , 2012
Appointment of Chairman and Acting CEO
The Board of Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) announces that Dr. Mal Brandon has been appointed to the position of Chairman of the Board.
The Board also wishes to announce that Ms. Alison Mew, the Company’s current Chief Operating Officer, has been appointed to the position of Acting Chief Executive Officer following the resignation of Dr. Paul MacLeman.
Dr. Brandon said “The Board is confident that the Company will continue to build on the solid foundation that has been created and looks forward to further expansion of its US operations and its global licensing programs”.
Dr. Malcolm R. Brandon Chairman
Genetic Technologies Limited (ABN 17 009 212 328) Phone: +61 3 8412 7000
Genetic Technologies Limited • Website : www.gtglabs.com • Email : [email protected] ABN 17 009 212 328 Registered Office • 60-66 Hanover Street Fitzroy Victoria 3065 Australia • Postal Address P.O. Box 115 Fitzroy Victoria 3065 Australia Phone +61 3 8412 7000 • Fax +61 3 8412 7040